Semma Therapeutics Overview
- Year Founded
-
2014
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$937M
Semma Therapeutics General Information
Description
Operator of a cell therapy and biotechnology company intended to develop transformative therapy with the curative use of stem cells in regenerative medicines. The company specializes in developing cell-based therapies for type 1 diabetes patients which traditionally require the use of an invasive insulin pump or multiple daily insulin injections combining proprietary cells with a state-of-the-art device, thereby eliminating the use of insulin injections and providing a functional cure for patients with diabetes.
Contact Information
Corporate Office
- 100 Technology Square
- Floor 3
- Cambridge, MA 02139
- United States
Semma Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Merger/Acquisition | 10-Oct-2019 | $937M | 00000 | 00000 | Completed | Generating Revenue |
4. Early Stage VC (Series B) | 30-Nov-2017 | 00000 | 00000 | Completed | Startup | |
3. Grant | 12-Sep-2016 | 000 | 0000 | Completed | Startup | |
2. Early Stage VC (Series A) | 24-Mar-2015 | $44M | $44M | 000.00 | Completed | Startup |
1. Spin-Off | 01-Dec-2014 | Completed | Startup |
Semma Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Semma Therapeutics Comparisons
Industry
Financing
Details
Semma Therapeutics Competitors (57)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Neurona Therapeutics | Venture Capital-Backed | South San Francisco, CA | 00 | 00000 | 00000000000 | 00000 |
Sernova | Corporation | London, Canada | 00 | 000.00 | 000000000 | 000.00 |
Seraxis | Venture Capital-Backed | Germantown, MD | 00 | 000.00 | 0000000000 0 | 000.00 |
NeuroNascent | Venture Capital-Backed | Clarksville, MD | 0 | 00.000 | 00000000000 | |
Gelesis | Formerly VC-backed | Boston, MA | 00 | 00000 | 000000&0 |
Semma Therapeutics Former Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
6 Dimensions Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
California Institute for Regenerative Medicine | Government | 000 0000 | 000000 0 | ||
Cowen Healthcare Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
Eight Roads | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |
Semma Therapeutics Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
CytoSolv | 16-Nov-2015 | 0000000000 | Biotechnology | 0000000 0 |
Semma Therapeutics FAQs
-
When was Semma Therapeutics founded?
Semma Therapeutics was founded in 2014.
-
Who is the founder of Semma Therapeutics?
Felicia Pagliuca Ph.D, Robert Millman JD, and Douglas Melton Ph.D are the founders of Semma Therapeutics.
-
Where is Semma Therapeutics headquartered?
Semma Therapeutics is headquartered in Cambridge, MA.
-
What industry is Semma Therapeutics in?
Semma Therapeutics’s primary industry is Biotechnology.
-
Is Semma Therapeutics a private or public company?
Semma Therapeutics is a Private company.
-
What is the current valuation of Semma Therapeutics?
The current valuation of Semma Therapeutics is 00000.
-
What is Semma Therapeutics’s current revenue?
The current revenue for Semma Therapeutics is 000000.
-
How much funding has Semma Therapeutics raised over time?
Semma Therapeutics has raised $158M.
-
Who are Semma Therapeutics’s investors?
6 Dimensions Capital, ARCH Venture Partners, California Institute for Regenerative Medicine, Cowen Healthcare Investments, and Eight Roads are 5 of 14 investors who have invested in Semma Therapeutics.
-
Who are Semma Therapeutics’s competitors?
Neurona Therapeutics, Sernova, Seraxis, NeuroNascent, and Gelesis are some of the 57 competitors of Semma Therapeutics.
-
When was Semma Therapeutics acquired?
Semma Therapeutics was acquired on 10-Oct-2019.
-
Who acquired Semma Therapeutics?
Semma Therapeutics was acquired by Vertex Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »